Exploring the potential of unique chemical compounds for new reactions
Uncovering Synthetic Potential of Distonic Radical Cations
This study is exploring a special type of chemical that can react in two ways at once, and by figuring out how to make these chemicals from certain amines, the researchers hope to create new methods for developing medicines that could help patients in the future.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arkansas at Fayetteville NIH-funded |
| Lab location | 1 site (Fayetteville, United States) |
| Project ID | NIH-10360129 on NIH RePORTER |
What this research studies
This research investigates distonic radical cations, which are unique chemical structures that can undergo two different reactions simultaneously. By developing a method to create these compounds from cyclopropyl- and cyclobutyl-amines, the researchers aim to overcome challenges related to their reactivity. The study focuses on controlling the conditions under which these compounds react, potentially leading to new ways to synthesize complex molecules. Patients may benefit from advancements in drug development and therapies that arise from these new chemical processes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by novel small molecules developed through this chemical research.
Not a fit: Patients with conditions that do not involve chemical treatments or those not affected by the types of compounds being studied may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapeutic compounds that improve treatment options for various medical conditions.
How similar studies have performed: While the approach to harnessing the reactivity of distonic radical cations is innovative, similar chemical strategies have shown promise in other research, indicating potential for success.
Where this research is happening
Fayetteville, United States
- University of Arkansas at Fayetteville — Fayetteville, United States (Active)
Researchers
- Principal investigator: Zheng, Nan — University of Arkansas at Fayetteville
- Study coordinator: Zheng, Nan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.